Researchers at Mayo Clinic recently together in a multidisciplinary effort to explore the impact of gender on quality of life for patients with newly diagnosed advanced cancer. It has been well documented that there are gender differences in the symptoms associated with cancer treatment. Mayo's randomized, controlled clinical trial studied 131 (45 women and 86 men, with a mean age 58.7) receiving radiotherapy for advanced cancer to test multidisciplinary interventions. Participants were measured through six sessions of structured interventions and compared to control subjects.
Outcome measures included the functional assessment of cancer therapy-general (FACT-G), linear analog self-assessment (LASA), and profile mood states (POMS) at baseline and weeks 4, 27 and 52.
Researchers found that gender-based differences appear to play a role in the early, but not late, response to a multidisciplinary intervention to improve quality of life for these patients, suggesting early interventions can be tailored for each gender.
Read the publication here.